Kiribati vs Macau, China: The number of people with susceptibility test result for rifampicin
Kiribati
177
in 2021
Macau, China
193
in 2021
Kiribati rank
96th
Macau, China rank
95th
The number of people with susceptibility test result for rifampicin over time
- Kiribati
- Macau, China
How they compare
Macau, China currently reports 193 against 177 in Kiribati, a difference of 16.
That makes Macau, China's figure about 1.1 times Kiribati's.
Across all 5 years both countries report, Macau, China has been ahead every year.
Kiribati ranks 96th and Macau, China ranks 95th of 155 countries.
Macau, China has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kiribati | Macau, China | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 115.67 | 220.33 | 104.67 | Macau, China |
| 2020s | 175.5 | 201 | 25.5 | Macau, China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Kiribati or Macau, China?
- Macau, China, at 193 against 177 in Kiribati as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Kiribati and Macau, China?
- 16, with Macau, China ahead.
- How many years of comparable data are there for Kiribati and Macau, China?
- 5 years are reported by both, from 2017 to 2021.
- How do Kiribati and Macau, China rank globally for the number of people with susceptibility test result for rifampicin?
- Kiribati ranks 96th and Macau, China ranks 95th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.